Excessive levels of glutamate, or related congeners, are thought to be associated with neuronal cell death in hypoxic-ischemic brain injury, epilepsy, trauma, and several degenerative neurological disorders such as Huntington's disease, Parkinsonism, and HIV-l-associated cognitive/motor complex (AIDS dementia) (reviewed in Rothman and Olney, 1987; Choi, 1988; Meldrum and Garthwaite, 1990; Lipton, 1992) . In many areas of the CNS, the predominant form of this neurotoxicity appears to be mediated by activation of the NMDA subtype of glutamate receptor and subsequent influx of excessive Ca2+. There is some evidence that NMDA open-channel blockers rather than competitive receptor antagonists may prove more useful in combatting the damage engendered by escalating levels of glutamate such as that observed following a stroke . One type of NMDA open-channel blocker is MK-801 (dizocilpine) (Huettner and Bean, 1988) , which has been shown to protect neurons from ischemic necrosis in gerbils and rats (Foster et al., 1988) . However, this type of dissociative anesthetic also impairs many normal neuronal functions and can cause injury or reversible neuronal swelling at therapeutic concentrations (Olney et al., 1989) . In contrast, we now report that another drug, memantine, which is known to be well tolerated clinically, is an NMDA open-channel blocker and uncompetitive antagonist. At least part of memantine's safety, compared to that of MK-801, may possibly be attributed to its unique rapid-response kinetics, which should allow substantial NMDA receptor function even in areas of potentially damaged neurons.
Memantine (I-amino-3,%dimethyladamantane hydrochloride) is known to have anti-Parkinsonian (Schneider et al., 1984) and anti-epileptic (Meldrum et al., 1986) properties and is an analog ofamantadine (1 -adamantanamine hydrochloride), a wellknown antiviral agent (Zlydnikov et al., 198 1) . Both adamantane derivatives have been used clinically for Parkinson's disease for many years in the United States or in Europe (Schwab et al., 1969; Schneider et al., 1984) . Recently, memantine was reported to block NMDA-evoked current in embryonic mouse spinal neurons (Bormann, 1989) . In the present study, we describe the molecular mechanism ofmemantine action and report that low micromolar concentrations, levels known to be therapeutic in Parkinson's disease (Wesemann et al., 1980 (Wesemann et al., , 1983 , prevent NMDA receptor-mediated neurotoxicity in both rat retinal ganglion cell and cortical neurons.
Materials and Methods
Cell culture. For retinal ganglion cell labeling, dissociation, and culture, we used techniques that have been detailed elsewhere (Leifer et al., 1984) . Briefly, retinal ganglion cells of 4-6-d-old Long-Evans rats were retrogradely labeled with granular blue by injection in the superior colliculus and retrograde transport. Two to six days later, the animals were killed by decapitation. Following enucleation, the retinas were dissociated with mild treatment with the enzyme papain. The retinal cells were then plated onto glass coverslips coated with poly-L-lysine in 35 mm tissue culture dishes. The growth medium was Eagle's minimum essential medium supplemented with 0.7% (w/v) methylcellulose, 0.3% (w/v) glucose, 2 mM glutamine, 5% (v/v) rat serum, and 1 fig/ml gentamicin. Retinal ganglion cells were identified by the presence of the retrogradely transported dye granular blue.
For the experiments with rat cortical cultures, cells were derived from embryonic (fetal day 15) Sprague-Dawley rats as described previously (Dichter, 1978; Rosenberg and Aizenman, 1989) . Following dissociation in 0.027% trypsin, cerebral cortical cells were plated at a density of 4.5 x lo5 per-j5 mm dish containing poly-L-lysine-coated glass coverslius in Dulbecco's modified Eaele's medium with Ham's F12 and heat-inactivated iron-supplemented calf serum (HyClone) at a ratio of 8: 1: 1, plus 2 mM glutamine, 24 mM HEPES, and 0.23% (w/v) penicillinstreptomycin. After 15 d in culture (when the astrocyte layer had become confluent), the cultures were treated with cytosine arabinoside for 72 hr. The culture medium was replenished three times weekly. Cultures were incubated at 36°C in a humidified atmosphere of 5% CO,, 95% air. The cultures were used for experiments at room temperature (21-24°C) approximately 1 month after plating. Patch-clamp electrophysiology. Whole-cell and single-channel recordings of rat retinal ganglion cells were performed as described in detail elsewhere (Hamill et al., 198 1; Lipton and Tauck, 1987) . The neurons were continuously superfused in a chamber at 27-29°C with a bath solution comuosed of (in mM) NaCl. 137.6: KCl. 5.8: CaCl,. 2.5: HEPES. 5; glucose, 25.2; withphenoired, d.OOl%'(v/vj; glicine, TpLMi pH 7.2; and no added magnesium. The patch pipettes were filled with an intracellular solution containing (in mM) CsCl, 120; tetraethylammonium chloride, 20; HEPES, 10; EGTA, 2.25; CaCl,, 1; and MgCl,, 2; and sometimes with 3 mM Mg-ATP to minimize rundown in prolonged recordings (pH 7.2). The agonists and antagonists were prepared in bath solution containing 1 PM tetrodotoxin (TTX), and they were applied by an array of pneumatic pipettes placed 20-50 pm from the neurons. Solution changes could be achieved rapidly, within 50-100 msec, by moving the array of constantly flowing pipette tips relative to the cell with a micromanipulator driver. A control pipette containing bath solution and 1 PM TTX was used to wash out NMDA-induced current rapidly; occasionally, the NMDA-evoked current was washed out in a slower fashion by the superfusate (as in Fig. 1 C) .
Measurement of intracellular calcium. Neuronal intracellular free Ca2+ concentration ([Ca*+],) was analyzed with fura-acetoxymethyl ester (Molecular Probes) following published procedures (Grynkiewicz et al., 1985) , and using a protocol for digital calcium imaging that has been detailed by this laboratory (Dreyer et al., 1990; Lipton et al., 1991; Sucher and Lipton, 199 1) . Drugs were administered by bath application or by pneumatic "puffer" pipettes. NMDA (200 PM) was always coapplied with glycine (1 PM).
Neurotoxicity studies. Rat retinal ganglion cell neurons surviving excitotoxic insult were scored by their ability to take up and cleave fluorescein diacetate to fluorescein as we have described previously (Hahn et al., 1988) . In six experiments, we monitored the effect of memantine or amantadine in attenuating NMDA receptor-mediated neurotoxicity of acutely isolated retinal ganglion cells that were cultured for 16-20 hr (Hahn et al., 1988; Sucher et al., 1991) .
For the neurotoxicity experiments on mixed neuronal and glial cortical cultures, the normal culture medium was exchanged at room temperature for Earle's Balanced Salt Solution (EBSS) without phenol red. Cultures were incubated for 30 min in NMDA or NMDA plus memantine. The culture medium was then replaced with fresh EBSS and the cultures were returned to the incubator overnight. The next day (-18 hr later) the cultures were fixed and scored for neuronal viability, as previously described (Rosenberg and Aizenman, 1989) , and verified with 0.2% trypan blue. Neurons were counted in a masked fashion in -30 micros&pic fields at 200 x . As an in vivo stroke model, under metofane anesthesia, 7-lo-d-old rats underwent bilateral carotid ligation followed by 25 min of hypoxia in 8% O,, similar to previously described procedures (Hattori et al., 1989) . One-half hour prior to the event, each animal was injected with an intraperitoneal loading dose of 20 mg/ml memantine (or saline in the case of the controls), and then received memantine maintenance doses of 1 mg/kg (or saline) at 12 hr intervals. Body temperature was regulated to 32-34°C with a water bath. After 48 hr, lesion size was measured by magnetic resonance imaging (MRI) with a 4.7 tesla magnetic resonance spectrometer (Bruker Biospec BMT 47/30 MR System). Images were obtained using the following scan parameters: T2 weighteh spin-echo images: TR. 2000: TE. 100. field of view. 2 x 2 cm: slice thickness, 1 mm; acquisitioh time, 16 min 53 sec.' A compu&zed analysis of infarct size was performed directly from these images. In addition, following fixation with 4% paraformaldehyde and embedding in paraffin, the brains were serially sectioned at 20 rrn and processed for routine histology with hematoxylin and eosin or cresyl violet staining to confirm MRI results.
Results
Open-channel blockade by memantine of NMDA-evoked whole-cell currents
In our initial experiments, we performed whole-cell recordings with patch electrodes to study the NMDA-evoked current on fluorescently labeled, postnatal rat retinal ganglion cells. We chose retinal ganglion cells because these central neurons could be grown in isolation, and thus we could reliably achieve the rapid application of drugs and solution changes that were necessary for the kinetic studies to determine the mode of action of memantine.
Work on retinal ganglion cell neurons Karschin et al., 1988) had revealed the presence of NMDA-evoked currents that were pharmacologically similar to other central neurons (MacDonald and Nowak, 1990 (Huettner and Bean, 1988; Semagor et al., 1989) .
The dissociation time constant of memantine from NMDA receptor channels was approximately 5.2 set at -60 mV in the continued presence of NMDA (Fig. lC, right) . This slow unblocking phase was no longer observed after preexposure to 3 mM magnesium
[a fast open-channel blocker of these NMDA receptor-operated ion channels (reviewed in MacDonald and Nowak, 1990)] (Fig. 1 C, left) . These findings suggest a blocking site of memantine that is possibly inside the channel pore, close to or interacting with Mg*+ binding site. In a competitive binding study using postmortem human brain homogenates, memantine was recently found to inhibit the binding of tritiated MK-801 (Komhuber et al., 1989) , also consistent with a mode of action within the channel pore. . When coapplied with agonist, 12 pM memantine did not affect the current elicited by 50 pM kainate (ZL4) or 5 PM quisqualate (QUZS), whereas the response to 200 PM NMDA was inhibited by 90% at -60 mV (n = 17) (right). C, Removal of 12 PM memantine resulted in a slow recovery of NMDA-induced current at -60 mV (right). This contrasts with the immediate recovery that has been observed following Mg 2+ block (reviewed by MacDonald and Nowak, 1990 ). Preexposure to 3 mM Mg*+ (left) prior to memantine not only blocked NMDA-induced current but also prevented antagonism by subsequent application of memantine, as evidenced by the absence of slow recovery following washout of both antagonists. A rapid application system was used to administer the drugs, and a fast washout method was used in the experiments shown in A and B. If indeed memantine plugs the pore of the open NMDA channel, then one would predict that the unblocking or "off" rate for memantine must be influenced by the membrane potential (Huettner and Bean, 1988; Semagor et al., 1989) . Empirically, this prediction has been substantiated. In the presence of 200 PM NMDA, the macroscopic unblocking time constant (T,& behaves as an exponential function of membrane potential over the range of -80 to +50 mV ( Fig. 2A) . At a holding potential of -60 mV, T,~ is 5.2 f 0.2 set (12 = 9), while at a holding potential of +50 mV, 7,11. is 0.7 * 0.1 set (n = 4).
The equilibrium dissociation constant (K,) of memantine is 1.2 FM at a holding potential of -60 mV, as measured from the dose-response curve of blockade (H.-S. V. Chen and S. A. Lipton, unpublished observations). The K, of memantine is also voltage dependent when calculated with an equation derived from a simplified model (Ascher et al., 1978 (Ascher et al., , 1979 Rang, 198 
with LY the on-rate constant and p, the off-rate constant, and
where Lro~ is the control current amplitude activated by NMDA; I MEM, the NMDA-activated current amplitude in the presence of memantine; and K,, the apparent equilibrium dissociation constant for NMDA, which was measured to be 50 PM from dose-response curves obtained in our preparation. Equation 2 was then used to calculate the K, of memantine at various membrane potentials. This calculation yielded a K, of 6.1 PM at 0 mV and 1.2 PM at -60 mV, which matches the K, measured in the dose-response experiments.
Next, we used the following equation (Woodhull, 1973) to estimate the fraction of the transmembrane field sensed by memantine:
where K,,,, is the equilibrium dissociation constant for memantine at a holding potential of 0 mV; 6, the fraction of the transmembrane potential field for extracellular application of memantine; V,,, the holding potential; Z, the charge of memantine at neutral pH, assumed to be equal to + 1 (Schneider et al., 1984) ; and F, R, and T have their usual meanings. The blocking site appears to sense approximately 70% of the transmembrane potential field for the extracellular application of memantine (6 = 0.7 1, calculated by the voltage dependence of K, with the Woodhull model). Memantine versus other organic NMDA antagonists In the case of memantine, the open-channel block represents a type of uncompetitive' inhibition because the NMDA receptoroperated ion channels must be activated, that is, opened, prior to a blocking agent moving into the voltage field of the pore to effect blockade; also, the apparent agonist affinity increases in the presence of antagonist (Chen and Lipton, unpublished observations). In uncompetitive antagonism, the degree of blockade in the presence of a fixed concentration of antagonist should increase with agonist concentration (Ascher et al., 1978 (Ascher et al., , 1979 Rang, 198 1) . This type of blockade has be& observed for memantine in our electrophysiology experiments with acute exposure to NMDA agonists ( Fig. 2B and inset) . At a holding potential of -60 mV, 6 FM memantine blocked -85% of the current evoked by 200 PM NMDA but ~58% of the current elicited by 5 PM NMDA. Furthermore, the absolute amplitude of residual agonist-evoked current during memantine blockade was about the same at different concentrations of NMDA (Fig.  2B , bottom current traces). Thus, in the face of escalating levels of EAAs, as observed in ischemia, the proportion of current inhibited by memantine actually increases, yet a basal level of NMDA-evoked response remains, unlike the effects of MK-80 1, which essentially blocks all NMDA-activated currents at these concentrations for a prolonged period of time (Huettner and Bean, 1988; Karschin et al., 1988) . Thus, in the presence of memantine, one might expect that physiological responses to NMDA should be relatively spared irrespective of the concentration of EAAs, permitting persistent receptor function. These pharmacological properties of memantine appear more advantageous than other organic NMDA open-channel blockers for the treatment ofacute NMDA-related neurotoxicity. At -70 mV, the blocking time constant for 10 /IM MK-801 (probably the most potent NMDA open-channel blocker) is reported to be about 8 set, and the unblocking time constant, -90 min (Huettner and Bean, 1988) . At this concentration [about lOOlOOO-fold above the reported K, of lo-30 nM (Wong et al., 1986; Foster and Wong, 1987) ], MK-801 blocks 90-99% of NMDA-evoked currents even at NMDA concentrations as low as 5 PM. This high degree ofblockade would allow only minimal basal glutamatergic neurotransmission in areas with normal glutamate levels and would thus result in untoward side effects. If, on the other hand, the high degree ofNMDA blockade is avoided by lowering the dose of MK-801, the blocking rate would become extremely slow and might not be effective in the prevention of acute glutamate neurotoxicity mediated by excessive NMDA receptor activation. In addition, the unblocking rate of MK-80 1 is much slower than memantine; hence, if side effects occur, a much longer time period is required to wash out MK- ' We do not discount the possibility, however, that long-term incubations (many hours) with memantine and very low concentrations of agonist could also result in a component of noncompetitive inhibition; under these conditions, memantine might bind to closed NMDA receptor-operated channels after entering through a hydrophobic pathway in the membrane. t trace at -60 mV induced by 20 and 50 PM NMDA illustrates that the relative degree of blockade by memantine was greater for the higher concentration of agonist. The degree of current blockade was calculated from the ratio of the steady-state current amplitude during memantine application relative to the steady-state current induced by NMDA alone just prior to memantine application. A rapid application and washout method system was used to administer the drugs. A, Single-channel activity elicited in a multichannel patch by 100 PM NMDA (left) and by simultaneous application of 100 PM NMDA plus 12 pM memantine (right) at a holding potential of -60 mV. Filtered at 5 kHz; digitization rate, 50 psec; for recording conditions, see Materials and Methods. B, Total amplitude histogram for patch in (A). Histograms were constructed (with a bin size of 0.04 PA) from a 4.9 set epoch for control (left) and 6.6 set for memantine (right), beginning about 30 set after the application of each solution. This delay ensured that channel activity approached steady state. The memantine record was longer in order to obtain a discernible number of events. Patch 201. C, Open-time histograms. To improve analysis, another patch (patch 207) was used containing very few overlapping events. Data were analyzed with idealized records by using a half-amplitude threshold criterion (Colquhoun and Sigworth, 1983) . As a first approximation to the study of the mechanism of memantine blockade, we did not attempt to resolve subconductance states, which would have complicated the analysis (Howe et al., 199 1) . To avoid these complications, we chose this patch because it had less subconductance transitions from the major conductance state of 45 pS. Data for the control histogram (left) were collected for 80 1 from the brain. Compared with other NMDA open-channel blockers, including ketamine, phencyclidine, and tricyclic antidepressants (Mayer et al., 1988; Wong and Kemp, 1991 ) the faster kinetics of action of low micromolar memantine, coupled with a K, of -1-2 PM at the resting potential, make this a relatively advantageous drug for the prevention of NMDA-related neurotoxicity.
Open-channel blockade by memantine of NMDA-evoked single-channel currents To demonstrate conclusively that the mode of action of memantine was open-channel block, we also performed singlechannel recordings. We found that 12 PM memantine blocked NMDA-evoked single-channel activity in outside-out patches. Application of 100 PM NMDA activated a burst of channel activity (Fig. 3A, left) . In conjunction with 12 PM memantine, however, 100 KM NMDA elicited only an initial burst of openings followed by decreasing channel activity (Fig. 3A, right) . The unitary channel conductance was not changed for the major amplitude of events (45 pS for this patch). The frequency of channel opening was reduced by -87% in the presence of memantine but never totally disappeared (Fig. 3B) . The events were also briefer after memantine application, consistent with blockade of open channels. A single exponential fit to the open time histogram revealed that the time constant (TJ was reduced from 6.4 msec to 4.1 msec by memantine (Fig. 30 , and recovered to 6.5 msec after antagonist washout. Initially, it may appear surprising that T, did not decrease to a greater degree. However, at a concentration of 12 WM memantine, the on rate of antagonist, calculated from macroscopic observations of K, and roR, is relatively slow compared to the channel closing rate (from Eqs. 1, 2; on-rate constant, 01 = 1 x lo5 Mmlsecc' at -60 mV; closing rate x 100-200 sect). This results in 7, being only somewhat shorter. In fact, at low micromolar concentrations of memantine, it is the decrease in opening frequency that accounts mainly for the reduction of macroscopic current. Taken together, the results of the single-channel and whole-cell recordings suggest that memantine selectively inhibits NMDA-elicited current by a mechanism of open-channel block.
Memantine attenuates NMDA-induced [Ca'+], responses
In parallel experiments, we found that memantine inhibited NMDA-evoked [Ca*+], responses. Early increases in [Ca"], are thought to be associated with delayed-onset NMDA receptormediated neurotoxicity (reviewed by Choi, 1988) . With digital calcium imaging techniques, 6 PM memantine largely prevented the excessive influx of calcium elicited by 200 PM NMDA (Fig.  4) . In fact in the presence of memantine, [CaZ+] , rose only to levels associated with a low degree of NMDA receptor stimulation. This result further supports the premise that memantine allows basal NMDA receptor-mediated responses but blocks excessive NMDA-evoked activity. Memantine ameliorates NMDA receptor-mediated neurotoxicity in vitro and in vivo In neurotoxicity experiments on cultures of both rat retinal ganglion cells and cortical neurons, 6-l 2 MM memantine prevented NMDA receptor-mediated neuronal injury (Fig. 5A-C) . As described elsewhere (Hahn et al., 1988; Sucher et al., 199 l) , in the retinal preparation an endogenous glutamate-like agonist produces neurotoxicity in the presence of elevated extracellular calcium and low magnesium concentrations (compare Fig. 5A ,B, columns 1, 2). This form of neuronal cell death is mediated by activation of the NMDA receptor because the NMDA-specific antagonists D,L-2-amino-5-phosphonovalerate (200 PM) or MK-801 (20 PM) prevented toxicity engendered by the endogenous substance (Hahn et al., 1988; Sucher et al., 199 1) . Memantine also prevented retinal ganglion cell death from the endogenous glutamate-related toxin in a dose-dependent manner, with complete salvage of neurons at 26 PM (Fig. 5A) . The related adamantane, amantadine, can also prevent neurotoxicity, but much higher concentrations are required (Fig. 5B) . The preventive effect of memantine can be generalized to other central neurons since NMDA receptormediated neurotoxicity was also inhibited in mixed cultures of cortical neurons and glia (Fig. SC) . In this case, 12 MM memantine completely prevented neuronal death due to a 30 min incubation in 50 PM NMDA. In addition, our in vivo experiments on neonatal rats and the experiments of other workers on adult rats (Seif el Nasr et al., 1990) demonstrate that memantine (1 O-20 mg/kg) can protect significantly from forebrain ischemia. For example, in neonatal rats we used MRI analysis 14.75 set, beginning 20 set after the initiation of 100 PM NMDA. We observed 1754 openings; of these, 174 1 events are included in the histogram (bin width, 200 psec). Data for the memantine histogram (right) were collected for 27.85 set, beginning immediately with memantine application. Because memantine drastically decreased the frequency of opening, this strategy was necessary to ensure sufficient events for analysis. For memantine, all 464 openings observed are included in the histogram. The value for the mean open time was estimated from the time constant (7,) of the single exponential fit to the open-time histogram (solid line). 7, is 6.4 msec for control (left) and 4.1 msec during memantine blockade (right). Thus, 7, was shortened by 36%. When the mean open times were calculated directly by digitally summing the dwell times over the entire record and dividing by the total number of events, similar figures were obtained (32% shortening). Similar results were observed in five patches. 8 mM) , while the other categories were exposed to high Ca2+/low Mg*+ (10 mM and 100 PM, respectively), which facilities NMDA receptor-mediated neurotoxicity in this preparation due to an endogenous glutamate-like agonist (Hahn et al., 1988; Sucher et al., 199 1) . Memantine and amantadine prevented this form of neuronal injury in a dose-dependent manner. The data in each graph represent three separate experiments, each conducted in triplicate and normalized to their respective controls (-150 retinal ganglion cells per control dish). C, Cortical neurons exposed to 50 PM NMDA are protected by 12 PM memantine.
Cortical cultures were scored for neurotoxicity as reported (Rosenberg and Aizenman, 1989) . Experiments were performed in triplicate and on separate days. The values shown represent mean and SEM. An ANOVA was used to test for significance followed Control Memantine Treated Figure 6 . Memantine ameliorates hypoxic-ischemic brain damage following bilateral carotid occlusion and hypoxia. Coronal sections of 9-d-old rat brains obtained 2 d following stroke. A, Representative control brain, which received only saline injections, sustained large, bilateral cortical infarcts with some involvement of underlying hippocampal structures. B, Brain treated with a 20 mg/kg loading dose of memantine followed by maintenance doses of 1 mg/kgll2 hr was relatively protected from damage. Based upon brain tissue concentration and elimination rate (Wesemann et al., 1983) , this dosing regimen resulted in a steadystate brain parenchymal level of = 10 PM. Hematoxylin and eosin stain.
to assess the size of large cerebral infarcts, defined as *50% forebrain injury in control animals 2 d post insult; memantine (20 mg/kg) decreased infarct size by 30 + 10% (mean + SEM; y1 = 5 pairs; p < 0.01 by Mann-Whitney U test). Histological sections (Fig. 6) verified the protection by memantine in the rat stroke model and closely paralleled the MRI results. Most importantly, in our experiments 20 mg/kg memantine did not produce lethargy or other behavioral side effects as observed with l-5 mg/kg of MK-80 1 in age-and strain-matched animals. Thus, our findings also have important implications for the action of memantine in preventing neuronal damage in viva t by a Scheffe test for multiple comparison of means. * and t indicate significantly less than control value (p < 0.0 1 and 0.05, respectively).
